About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Risk Stratification of Nodal PTCL

Risk Stratification of Nodal PTCL

NCT03040206·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Chonbuk National University Hospital

With

Chonnam National University Hospital
Kyungpook National University Hospital
Keimyung University Dongsan Medical Center
Korea University Anam Hospital
Korea University Guro Hospital
Dong-A University Hospital
Pusan National University Hospital
Yeungnam University Hospital
Inje University
Chungnam National University Hospital
Samsung Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients diagnosed with nodal PTCLs (PTCL, NOS; Angioimmunblastic T-cell lymphoma; anaplastic large cell lymphoma \[ALCL\], anaplastic lymphoma kinase \[ALK\]-negative)
Patients diagnosed with between January 1, 2004 and April 30, 2016
initially treated with curative intent
Patients with standard 18F-fluorodeoxyglucose (FDG) PET or PET-CT data at the time of diagnosis and at the end of primary treatment

You may not be if

Patients diagnosed with extranodal PTCLs, including followings (extranodal NK/T-cell lymphoma, nasal type; enteropathy-associated T-cell lymphoma; hepatosplenic T-cell lymphoma; subcutaneous panniculitis-like T-cell lymphoma; EBV-positive T-cell lymphoproliferative childhood disorders, and primary cutaneous lymphomas)
Patients with ALCL-ALK+
Patients who do not have 18F-FDG PET or PET-CT data either at diagnosis or at the end of treatment available for review

The record

StatusCompleted

PhaseNo phase

Taking part405

StartedJan 2017

UpdatedAug 7, 2019

Conditions

Peripheral T-Cell Lymphoma, Not Otherwise Specified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma, ALK-negative

Where1

Chonbuk Nationla University Hospital
Jeonju, South Korea